PTK2 and neoplasm: Additionally, inhibition of FAK using a selective FAK inhibitor, VS‐4718, was shown to reduce tumor fibrosis, decrease the number of tumor‐infiltrating immunosuppressive cells, and thereby reduce tumor progression and result in doubling survival in KPC mice [141].